No Data
Insmed To Present at the BofA Securities Health Care Conference 2024
We Think Some Shareholders May Hesitate To Increase Insmed Incorporated's (NASDAQ:INSM) CEO Compensation
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
BRIDGEWATER, N.J., April 25, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
Express News | Insmed Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $48
Insmed Initiated at Buy by Truist Securities
Insmed Initiated at Buy by Truist Securities
Analysts Conflicted on These Healthcare Names: Cartesian Therapeutics (RNAC), Insmed (INSM) and BioNTech SE (BNTX)